SI9111842A - Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba - Google Patents

Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba Download PDF

Info

Publication number
SI9111842A
SI9111842A SI9111842A SI9111842A SI9111842A SI 9111842 A SI9111842 A SI 9111842A SI 9111842 A SI9111842 A SI 9111842A SI 9111842 A SI9111842 A SI 9111842A SI 9111842 A SI9111842 A SI 9111842A
Authority
SI
Slovenia
Prior art keywords
sodium
enalapril
salt
added
formulation
Prior art date
Application number
SI9111842A
Other languages
English (en)
Slovenian (sl)
Inventor
Marjo Merslavi
Jo�ica Ra�en
Ale Rotar
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25555813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9111842(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka filed Critical Krka
Publication of SI9111842A publication Critical patent/SI9111842A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SI9111842A 1991-11-25 1991-11-25 Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba SI9111842A (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU184291A YU48602B (sh) 1991-11-25 1991-11-25 Postupak za dobijanje stabilne formulacije soli enalaprila

Publications (1)

Publication Number Publication Date
SI9111842A true SI9111842A (sl) 1998-04-30

Family

ID=25555813

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9111842A SI9111842A (sl) 1991-11-25 1991-11-25 Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba

Country Status (11)

Country Link
US (1) US5350582A (fr)
EP (1) EP0545194B1 (fr)
AT (1) ATE150650T1 (fr)
CA (1) CA2083683C (fr)
DE (1) DE69218557T2 (fr)
DK (1) DK0545194T3 (fr)
ES (1) ES2101004T3 (fr)
GR (1) GR3023655T3 (fr)
HR (1) HRP921482B1 (fr)
SI (1) SI9111842A (fr)
YU (1) YU48602B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011034509A2 (fr) 2009-09-21 2011-03-24 Silverstone Pharma Nouveaux sels de benzathine d'inhibiteurs de ace, procédé pour leur préparation et leur utilisation pour le traitement de maladies cardiovasculaires

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128199C (fr) * 1994-07-15 1997-02-04 Bernard Charles Sherman Compositions pharmaceutiques, solides, stables, renfermant du maleate d'enalapril
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
GB9521781D0 (en) * 1995-10-24 1996-01-03 Merck Sharp & Dohme Therapeutic agents
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
CA2302832A1 (fr) * 1998-07-21 2000-02-03 Kaneka Corporation Procede de cristallisation d'un sel d'acide maleique de n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline
NZ333206A (en) 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
HU226950B1 (en) * 1999-11-03 2010-03-29 Richter Gedeon Nyrt The magnesium salt of enalapril and antihypertensive pharmaceutical composition containing it
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
RS53324B (en) 2005-11-17 2014-10-31 Silverstone Pharma Est. STABLE FORMULATION OF AMORPHIC SALES OF PERINDOPRIL, PROCEDURE FOR THEIR PREPARATION, IN PARTICULAR INDUSTRIAL PREPARATION, AND THEIR USE IN HYPERTENSION THERAPY
WO2011161223A2 (fr) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Formes pharmaceutiques à usage oral comprenant de la lercanidipine et de l'énalapril et leurs sels pharmaceutiquement acceptables
EP2654729B1 (fr) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Formes pharmaceutiques orales homogènes comprenant de la lercanidipine et de l'énalapril ou leurs sels pharmaceutiquement acceptables ainsi qu'un acide organique
CA2922536C (fr) 2013-08-28 2022-05-03 Psychemedics Corporation Test d'integrite d'echantillons de cheveux
RS58120B1 (sr) 2014-07-31 2019-02-28 Pharmathen Sa Kompozicija orodisperzibilnog filma koja sadrži enalapril za lečenje hipertenzije kod pedijatrijske populacije

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
EP0391462A1 (fr) * 1989-04-05 1990-10-10 Janssen Pharmaceutica N.V. Combinaisons synergiques à kétanserin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011034509A2 (fr) 2009-09-21 2011-03-24 Silverstone Pharma Nouveaux sels de benzathine d'inhibiteurs de ace, procédé pour leur préparation et leur utilisation pour le traitement de maladies cardiovasculaires

Also Published As

Publication number Publication date
EP0545194A1 (fr) 1993-06-09
GR3023655T3 (en) 1997-09-30
DE69218557D1 (de) 1997-04-30
CA2083683C (fr) 2000-09-05
ATE150650T1 (de) 1997-04-15
HRP921482B1 (en) 2000-04-30
CA2083683A1 (fr) 1993-05-26
YU184291A (sh) 1994-04-05
DK0545194T3 (da) 1997-07-28
EP0545194B1 (fr) 1997-03-26
HRP921482A2 (en) 1996-12-31
US5350582A (en) 1994-09-27
DE69218557T2 (de) 1997-11-13
YU48602B (sh) 1998-12-23
ES2101004T3 (es) 1997-07-01

Similar Documents

Publication Publication Date Title
SI9111842A (sl) Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
CA1165689A (fr) Methode pour augmenter l'absorption orale d'agents bioactifs polaires
KR100324451B1 (ko) 프로톤펌프억제제를함유하는수의용조성물
US4113882A (en) Stabilized oral prostaglandin formulation and the process for the preparation thereof
US6004951A (en) Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
HRP20020182A2 (en) Benzamide formulation with histone deacetylase inhibitor activity
UA29513C2 (uk) Фармацевтична композиція, що включає (е)-3,5-дигідрокси-7-[4'-4''-фторфеніл-2'-циклопропілхінолін-3'-іл]-6- гептенову кислоту
DK162840B (da) Zink(ii)-komplekser af substituerede 3-hydroxypyroner eller 3-hydroxypyridoner, anvendelse af disse samt farmaceutiske praeparater indeholdende disse
EA004431B1 (ru) Новая форма соли пантопразола, ее применение и лекарственное средство (варианты)
US3634583A (en) Pharmaceutical composition for the treatment of oedematous conditions and hypertension
HU194733B (en) Process for producing lactate solutions of piperazinyl-quinolone- and piperazinyl-azaquinolone-carboxylic acids
HU229213B1 (en) Method for stabilizing benzimidazole compounds
JPS6411007B2 (fr)
AU3932199A (en) Pharmaceutical preparation containing levothyroxine sodium
AU743043B2 (en) Pharmaceutical preparations of cilansetron stabilized against racemization
KR0147855B1 (ko) 골형성 촉진제
US3362879A (en) Tyrosine tranquilizing compositions and methods of treatment
GB2061111A (en) Long acting pharmaceutical composition
US3501577A (en) Method of treating hypertension with alkali metal salts of zinc diethylenetriaminepentaacetate
SI9110908A (sl) Inkluzijski kompleksi N-etoksikarbonil-3-morfolino-sidnonimina ali soli tvorjeni z derivati ciklodekstrina, njihovo pridobivanje in farmacevtski pripravki, ki jih vsebujejo
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
JP2002284679A (ja) 安定な甲状腺ホルモン含有固形製剤組成物
HU196554B (en) Process for production of medical compounds with fungicidal effect
HU210641B (en) Process to stabilize 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide
KR920008161B1 (ko) 오메프라졸 경구용 약제의 제조방법